Carboxylic acid salts
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 764.82 g/mol | C32H37N5O6·3/2 C4H6O4 | 25 MG
Tasurgratinib succinate is an orally available, selective small-molecule inhibitor of fibroblast growth factor receptors FGFR1, FGFR2, and FGFR3. Supplied as the succinate salt for research use, the compound is characterized by a defined molecular formula and high purity for preclinical and translational studies probing FGFR-driven signaling and anticancer activity.
- Selective FGFR1-3 inhibition with low nanomolar potency.
- High reported purity suitable for research applications.
- Supplied as a succinate salt for improved stability and handling.
- Molecular weight and formula provided for analytical characterization.
- Soluble in common organic solvents for in vitro testing.
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 764.8 g/mol | C32H37N5O6·3/2C4H6O4 | 50 MG
E7090 succinate (tasurgratinib succinate) is the succinate salt of tasurgratinib, an orally active small-molecule inhibitor selective for fibroblast growth factor receptors FGFR1-3. It is supplied as a high-purity research compound with documented solubility and in vivo formulation protocols for preclinical studies.
eMolecules 28303-42-6 | DODECYL FORMATE | AstaTech214.349 | C13H26O2 | 95.000 | CCCCCCCCCCCCOC=O | 0.25g | 696743638
DODECYL FORMATE | AstaTech | 28303-42-6214.349 | C13H26O2 | 95.000 | CCCCCCCCCCCCOC=O | 0.25g | 696743638
![eMolecules 1051375-19-9 | Dolutegravir Sodium | Toronto Research Chemicals | MFCD28405599 | 441.367 | C20H18F2N3NaO5 | 95.000 | [Na+].C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12 | 100mg | 483404592](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000190356.jpg-250.jpg)
eMolecules 1051375-19-9 | Dolutegravir Sodium | Toronto Research Chemicals | MFCD28405599 | 441.367 | C20H18F2N3NaO5 | 95.000 | [Na+].C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12 | 100mg | 483404592
Dolutegravir Sodium | Toronto Research Chemicals | 1051375-19-9 | MFCD28405599 | 441.367 | C20H18F2N3NaO5 | 95.000 | [Na+].C[C@@H]1CCO[C@H]2Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c([O-])c3C(=O)N12 | 100mg | 483404592
![Medchemexpress LLC 2-(2,3-dihydro-1,3,6-trimethyl-2-oxo-1H-benzimidazol-5-yl)-6-(3-hydroxypropyl)-benz[de]isoquinoline | 2080306-23-4 | MFCD30480933 | 99.4% | 429.47 g·mol⁻¹ | C25H23N3O4 | 1 ML](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000241016.png-250.jpg)
Medchemexpress LLC 2-(2,3-dihydro-1,3,6-trimethyl-2-oxo-1H-benzimidazol-5-yl)-6-(3-hydroxypropyl)-benz[de]isoquinoline | 2080306-23-4 | MFCD30480933 | 99.4% | 429.47 g·mol⁻¹ | C25H23N3O4 | 1 ML
BAY-299 is a small-molecule chemical probe that selectively targets bromodomain-containing proteins, inhibiting BRPF2 (BRD1) and the second bromodomains of TAF1 and TAF1L. It is used in biochemical and cell-based research to probe bromodomain function and epigenetic regulation.
- Potent dual inhibitor with reported IC50s: BRPF2 BD 67 nM, TAF1 BD2 8 nM, TAF1L BD2 106 nM.
- High purity as supplied: 99.4% (HPLC).
- Chemical formula C25H23N3O4 and molecular weight 429.47 g·mol⁻¹.
- Available as a 10 mM solution in DMSO (1 mL) and as solid quantities from 5 mg to 500 mg.
- Supplied with SMILES and structure information for computational and cheminformatics use.
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 764.82 g·mol⁻¹ | C32H37N5O6 · 3/2 C4H6O4 | 5 MG
Tasurgratinib succinate is the succinate salt of an orally active, selective inhibitor of FGFR1-3 used in preclinical and research applications. The compound shows low-nanomolar potency against FGFR1, FGFR2, and FGFR3 and is supplied as a high-purity solid or as a DMSO solution for laboratory studies.
- High purity suitable for research use.
- Potent FGFR1/2/3 inhibition at low nanomolar concentrations.
- Available as solid and as DMSO solution for assay flexibility.
- Soluble in DMSO at high concentration (≈100 mg/mL).
- Pack sizes appropriate for preclinical experiments.
![eMolecules 4,4-bis(octyloxy)butanoic acid sodium salt | Broadpharm |366.518 | C20H39NaO4 | 95.000 | [Na+].CCCCCCCCOC(CCC([O-])=O)OCCCCCCCC | 250mg | 698443044](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502475231.JPG-250.jpg)
eMolecules 4,4-bis(octyloxy)butanoic acid sodium salt | Broadpharm |366.518 | C20H39NaO4 | 95.000 | [Na+].CCCCCCCCOC(CCC([O-])=O)OCCCCCCCC | 250mg | 698443044
4,4-bis(octyloxy)butanoic acid sodium salt | Broadpharm |366.518 | C20H39NaO4 | 95.000 | [Na+].CCCCCCCCOC(CCC([O-])=O)OCCCCCCCC | 250mg | 698443044
Cayman Chemical Fluvastatin sodium salt hydr
An HMG-CoA reductase inhibitor (Ki = 0.3 nM for the rat enzyme); inhibits CYP2C9 (IC50 = 100 nM); inhibits oxidized LDL-induced ferroptosis and reverses oxidized LDL-induced decreases in GPX4 and system Xc- levels in HUVECs; decreases serum cholesterol, triglyceride, and phospholipid levels, the formation of TBARS, and vascular ACE activity in rabbits fed a high-cholesterol diet at 2 mg/kg per day; increases survival in a mouse model of myocardial infarction at 10 mg/kg per day
Chem-Impex International, Inc. L-Lactic acid lithium salt | 27848-80-2 | MFCD00065512 | 5G
L-Lactic acid lithium salt, 27848-80-2, MFCD00065512, 5G